Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony R Green

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Blood|December 8, 2017
Myeloproliferative neoplasms: from origins to outcomesJyoti Nangalia, Anthony R Green
Blood|July 3, 2020
Mutant CALR functions: gains and lossesDaniel Prins, Anthony R Green
Hematology. American Society of Hematology. Education Program|December 10, 2017
Myeloproliferative neoplasms: from origins to outcomesJyoti Nangalia, Anthony R Green
Hematology. American Society of Hematology. Education Program|November 24, 2005
Management of polycythemia vera and essential thrombocythemiaPeter J Campbell, Anthony R Green
Cold Spring Harbor Perspectives in Medicine|January 19, 2017
Order Matters: The Order of Somatic Mutations Influences Cancer EvolutionDavid G Kent, Anthony R Green
Hematology/Oncology Clinics of North America|October 17, 2003
Essential thrombocythemiaClaire N Harrison, Anthony R Green
Mayo Clinic Proceedings|February 14, 2006
The long-term outlook for essential thrombocythemiaPeter J Campbell, Anthony R Green
Best Practice & Research. Clinical Haematology|June 20, 2006
Essential thrombocythaemiaClaire N Harrison, Anthony R Green
Hematology/Oncology Clinics of North America|September 27, 2012
Genotype-phenotype interactions in the myeloproliferative neoplasmsAnna L Godfrey, Anthony R Green
The New England Journal of Medicine|December 8, 2006
The myeloproliferative disordersPeter J Campbell, Anthony R Green
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Blood|December 8, 2017
Myeloproliferative neoplasms: from origins to outcomesJyoti Nangalia, Anthony R Green
Blood|July 3, 2020
Mutant CALR functions: gains and lossesDaniel Prins, Anthony R Green
Hematology. American Society of Hematology. Education Program|December 10, 2017
Myeloproliferative neoplasms: from origins to outcomesJyoti Nangalia, Anthony R Green
Hematology. American Society of Hematology. Education Program|November 24, 2005
Management of polycythemia vera and essential thrombocythemiaPeter J Campbell, Anthony R Green
Cold Spring Harbor Perspectives in Medicine|January 19, 2017
Order Matters: The Order of Somatic Mutations Influences Cancer EvolutionDavid G Kent, Anthony R Green
Hematology/Oncology Clinics of North America|October 17, 2003
Essential thrombocythemiaClaire N Harrison, Anthony R Green
Mayo Clinic Proceedings|February 14, 2006
The long-term outlook for essential thrombocythemiaPeter J Campbell, Anthony R Green
Best Practice & Research. Clinical Haematology|June 20, 2006
Essential thrombocythaemiaClaire N Harrison, Anthony R Green
Hematology/Oncology Clinics of North America|September 27, 2012
Genotype-phenotype interactions in the myeloproliferative neoplasmsAnna L Godfrey, Anthony R Green
The New England Journal of Medicine|December 8, 2006
The myeloproliferative disordersPeter J Campbell, Anthony R Green
Pageof 20